Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

VEGF Protein (AA 27-190)

Protéine Recombinant VEGF exprimée dans HEK-293 Cells.
N° du produit ABIN2181901

Aperçu rapide pour VEGF Protein (AA 27-190) (ABIN2181901)

Antigène

Voir toutes VEGF Protéines
VEGF (Vascular Endothelial Growth Factor (VEGF))

Type de proteíne

Recombinant

Activité biologique

Active

Origine

  • 14
  • 5
  • 1
  • 1
Souris

Source

  • 6
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
HEK-293 Cells

Pureté

>95 % as determined by SDS-PAGE.

Classe de qualité

HPLC verified
  • Attributs du protein

    AA 27-190

    Marque

    ActiveMax®

    Séquence

    AA 27-190

    Attributs du produit

    This protein carries no "tag". The protein has a calculated MW of 19.3 kDa. The protein migrates as 23-25 kDa under reducing (R) condition (SDS-PAGE) due to different glycosylation.

    Stérilité

    0.22 μm filtered

    niveau d'endotoxine

    Less than 1.0 EU per μg by the LAL method.
  • Vous souhaitez d'autres options pour ce Protein ?

    !
    Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !

    Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Buffer

    PBS, pH 7.4

    Conseil sur la manipulation

    Please avoid repeated freeze-thaw cycles.

    Stock

    -20 °C

    Stockage commentaire

    No activity loss was observed after storage at: In lyophilized state for 1 year (4 °C), After reconstitution under sterile conditions for 3 months (-70 °C).
  • Antigène

    VEGF (Vascular Endothelial Growth Factor (VEGF))

    Autre désignation

    VEGF

    Sujet

    Vascular endothelial growth factor A (VEGFA) is also known as Vascular permeability factor (VPF). VEGFA belongs to the PDGF/VEGF growth factor family. VEGFA is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. VEGFA is produced by a group of three major isoforms as a result of alternative splicing and if any three isoforms are produced (VEGFA120, VEGFA164, and VEGFA188) then this will not result in vessel defects and death of the full VEGFA knockout in mice.

    Poids moléculaire

    19.3 kDa
Vous êtes ici:
Chat with us!